Market cap of Israelfounded Novocure exceeds $9b

Market cap of Israel-founded Novocure exceeds $9b

The company's electrical stimulation treatment for brain cancer can extend patients' lives by years.

Original Article: Market cap of Israel-founded Novocure exceeds $9b

More From BioPortfolio on "Market cap of Israel-founded Novocure exceeds $9b"